Höller Konstantin, Fabeni Lavinia, Herling Marco, Holtick Udo, Scheid Christof, Knops Elena, Lübke Nadine, Kaiser Rolf, Pfister Herbert, Di Cristanziano Veronica
Institute of Virology, University of Cologne, Cologne, Germany.
National Institute for Infectious Diseases L. Spallanzani - IRCCS, Rome, Italy.
Eur J Haematol. 2017 Aug;99(2):133-140. doi: 10.1111/ejh.12895. Epub 2017 May 30.
Aim of this retrospective study was to analyze the dynamics of BKPyV reactivation in allogeneic hematopoietic stem cell transplant recipients in order to identify patients with higher risk to develop BKPyV-associated hemorrhagic cystitis (BKPyV-associated HC).
The study included 58 allo-HSCT recipients from the University Hospital of Cologne detected BKPyV positive by real-time PCR between 2009 and 2015. For correlative analysis, the first detected BKPyV-DNA load in urine and in plasma as well as the onset and severity of HC following the first day of conditioning regimen was considered. Phylogenetic analysis of BKPyV isolates was performed.
In 25 of 58 patients, BKPyV-DNA was detected in urine only (group U), whereas 33 patients developed additional viremia (group P). A chronologic sequence viruria-viremia-HC was identified. Viral load of >10 copies/mL at first viruria and evidence of viremia after 45 days from the start of conditioning represented risk factors for the onset of HC. Molecular characterization revealed a non-stereotypic distribution of viral subtypes across groups U and P.
Monitoring of BKPyV-DNA by real-time PCR after initiation of conditioning, regularly performed in clinical practice, can be a crucial tool for the early identification of patients with higher risk of BKPyV-associated HC.
本回顾性研究旨在分析异基因造血干细胞移植受者中BK病毒(BKPyV)再激活的动态变化,以识别发生BKPyV相关出血性膀胱炎(BKPyV相关HC)风险较高的患者。
该研究纳入了2009年至2015年间在科隆大学医院通过实时PCR检测出BKPyV阳性的58例异基因造血干细胞移植受者。为进行相关性分析,考虑了首次在尿液和血浆中检测到的BKPyV-DNA载量,以及预处理方案第一天后HC的发病情况和严重程度。对BKPyV分离株进行了系统发育分析。
58例患者中有25例仅在尿液中检测到BKPyV-DNA(U组),而33例患者出现了额外的病毒血症(P组)。确定了病毒尿-病毒血症-HC的时间顺序。首次病毒尿时病毒载量>10拷贝/mL以及预处理开始后45天出现病毒血症的证据是HC发病的危险因素。分子特征显示病毒亚型在U组和P组之间呈非定型分布。
在临床实践中常规进行预处理后通过实时PCR监测BKPyV-DNA,可能是早期识别BKPyV相关HC高风险患者的关键工具。